Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated 29 min ago
Peer-reviewedCC BY 4.0JAMA Network Open

Payers’ Views on Expanding Their Role in Precision Medicine

  • Julia R. Trosman1,2,3
  • Christine B. Weldon1,3
  • Emily Hammad Mrig1,2
  • Kathryn A. Phillips1,2
  1. 1UCSF Center for Translational and Policy Research on Precision Medicine, San Francisco, California
  2. 2Department of Clinical Pharmacy, University of California, San Francisco
  3. 3Center for Business Models in Healthcare, Glencoe, Illinois
Open at sourceDOICite

Abstract

This qualitative study explores the views of US private health care payers regarding evidence and policy challenges of precision medicine, as well as their potential roles in its implementation.

Related

  1. Editorial: Translational strategies for chronic lung diseases: emerging therapies and precision medicine
    Poonam Arora, Lalit Mohan Nainwal
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Full textPharmacology & toxicologyCrossref
  2. Paradigm shifts in prostate biopsy strategies in the era of precision medicine
    Chenhui Tang, Zhen Liang, Weigang Yan
    Frontiers in surgeryPeer-reviewedCC BYFull textSurgery & anaesthesiaEurope PMC
  3. Evolution of Precision Oncology, Personalized Medicine, and Molecular Tumor Boards
    Yu Fujiwara, Shumei Kato, Razelle Kurzrock
    Hematology/Oncology Clinics of North AmericaPeer-reviewedLicence not stated21 citedOncologyOpenAlex
  4. Sepsis-associated liver injury: from liver-test risk signals to immunobiology-guided precision medicine
    Antonios Katsounas, Emmanuel Tsochatzis, Jordi Rello
    Intensive Care MedicinePeer-reviewedLicence not statedFull textEpidemiology & public healthHAL
  5. The maturation of precision medicine into pragmatic, patient-centered care: A commentary on the 2026 EHA CLL Guidelines.
    Stefano Molica, Talha Munir, David Allsup
    HemaSpherePeer-reviewedCC BY-NC-NDFull text1 citedHuman geneticsEurope PMC

Cite

BibTeXRIS
BibTeX
@article{trosman2026payers,
  title = {{Payers’ Views on Expanding Their Role in Precision Medicine}},
  author = {Julia R. Trosman and Christine B. Weldon and Emily Hammad Mrig and Kathryn A. Phillips},
  journal = {JAMA Network Open},
  year = {2026},
  month = oct,
  doi = {10.1001/jamanetworkopen.2026.37774},
  url = {https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854764},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Payers’ Views on Expanding Their Role in Precision Medicine
AU  - Julia R. Trosman
AU  - Christine B. Weldon
AU  - Emily Hammad Mrig
AU  - Kathryn A. Phillips
PY  - 2026
DA  - 2026/10/02
JO  - JAMA Network Open
DO  - 10.1001/jamanetworkopen.2026.37774
UR  - https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2854764
AB  - This qualitative study explores the views of US private health care payers regarding evidence and policy challenges of precision medicine, as well as their potential roles in its implementation.
SN  - 2574-3805
ER  -